Detalhe da pesquisa
1.
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
Oncologist
; 28(7): 642-e561, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37134294
2.
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
BJU Int
; 127(4): 435-444, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969563
3.
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
BJU Int
; 118(4): 590-7, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780387
4.
Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.
Cancer Immunol Immunother
; 63(3): 225-34, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24327292
5.
Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.
Cancer Immunol Immunother
; 62(6): 1011-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591984
6.
Recent advances revolutionize treatment of metastatic prostate cancer.
Future Oncol
; 9(8): 1133-44, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23902245
7.
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.
Lancet Oncol
; 13(5): 501-8, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22326924
8.
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.
Eur Urol Oncol
; 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858437
9.
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
J Exp Clin Cancer Res
; 42(1): 76, 2023 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991390
10.
Neoantigens in the immuno-oncology space.
Future Oncol
; 13(25): 2209-2211, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28976211
11.
Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas.
Cancers (Basel)
; 14(13)2022 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804808
12.
Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201.
Cancers (Basel)
; 14(20)2022 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291783
13.
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
Cancer Immunol Immunother
; 60(2): 197-206, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20976449
14.
Development of a serum biomarker assay that differentiates tumor-associated MUC5AC (NPC-1C ANTIGEN) from normal MUC5AC.
J Biomed Biotechnol
; 2011: 934757, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21197415
15.
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer.
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33664086
16.
New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.
Cancer Immunol Immunother
; 59(1): 63-71, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19495750
17.
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.
Cancer Immunol Immunother
; 59(5): 663-74, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19890632
18.
A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer.
J Urol
; 183(6): 2219-26, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20399458
19.
Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer.
Clin Cancer Res
; 26(14): 3557-3564, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303539
20.
Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer.
Front Oncol
; 10: 805, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32637350